2023. Targeting toll-like receptor 4 and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy. Biomolecules and Biomedicine. (Dec. 2023). DOI:https://doi.org/10.17305/bb.2023.9838.